Gallbladder Adenocarcinoma Overview

Save information for later
Sign Up

Learn About Gallbladder Adenocarcinoma

View Main Condition: Gallbladder Cancer

What is the definition of Gallbladder Adenocarcinoma?
Gallbladder adenocarcinoma is a type of cancer that starts in gland-like cells that line the gallbladder. The gallbladder is a small pear-shaped organ below the liver that stores bile, which is a digestive fluid.
What are the symptoms of Gallbladder Adenocarcinoma?
Gallbladder adenocarcinoma may not have any symptoms until the late stages of the disease. Symptoms of gallbladder adenocarcinoma may include nausea and vomiting, loss of appetite, fever, abdominal bloating, abdominal pain in the right upper side, abdominal lumps, unexplained weight loss, itchy skin, dark urine, pale or greasy stools, and yellowing of the whites of the eyes and skin.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Gallbladder Adenocarcinoma?
Treatment for gallbladder adenocarcinoma depends on the stage, or how far it has progressed. Treatments for gallbladder adenocarcinoma include surgery, chemotherapy, radiation therapy, targeted drug therapy, and immunotherapy.
Who are the top Gallbladder Adenocarcinoma Local Doctors?
Dr. Frederick T. Drake
General Surgery
Dr. Frederick T. Drake
General Surgery

Boston University General Surgical Associates, Inc.

1 Boston Medical Ctr Pl, 
Boston, MA 
 (24.0 mi)
617-638-8605
Experience:
17+ years
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Frederick Drake is a General Surgeon in Boston, Massachusetts. Dr. Drake has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Appendicitis, Hyperparathyroidism, Gallbladder Adenocarcinoma, Appendectomy, and Parathyroidectomy. Dr. Drake is currently accepting new patients.

Dr. Anasuya Gunturi
Hematology | Oncology
Dr. Anasuya Gunturi
Hematology | Oncology

Lgh Medical Group, Inc.

295 Varnum Ave, 
Lowell, MA 
 (1.6 mi)
978-788-7344
Experience:
16+ years
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Anasuya Gunturi is a Hematologist and an Oncologist in Lowell, Massachusetts. Dr. Gunturi has been practicing medicine for over 16 years and is rated as an Experienced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. Her top areas of expertise are Inflammatory Breast Cancer, Paget Disease of the Breast, Breast Cancer, and Angiosarcoma. Dr. Gunturi is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Nadia M. Murray, NP
Nurse Practitioner
Nadia M. Murray, NP
Nurse Practitioner

Lgh Medical Group, Inc.

295 Varnum Ave, 
Lowell, MA 
 (1.6 mi)
978-788-7344
Experience:
14+ years
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Nadia Murray is a Nurse Practitioner in Lowell, Massachusetts. Murray has been practicing medicine for over 14 years and is rated as an Experienced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. Her top areas of expertise are Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), ALK-Positive Non-Small Cell Lung Cancer, and Gallbladder Adenocarcinoma. Murray is currently accepting new patients.

View All Doctors
What are the latest Gallbladder Adenocarcinoma Clinical Trials?
Safety and Feasibility of Prophylactic Heated Intra-peritoneal Chemotherapy (HIPEC) for High-Risk Gallbladder Adenocarcinoma
Safety and Feasibility of Prophylactic Heated Intra-peritoneal Chemotherapy (HIPEC) for High-Risk Gallbladder Adenocarcinoma
Enrollment Status: Recruiting
Publish Date: February 24, 2025
Intervention Type: Drug
Study Phase: Early Phase 1

Summary: Gallbladder adenocarcinoma is a devastating disease associated with a poor prognosis. Gallbladder and other biliary cancers will be responsible for an estimated 11,980 new cases, and 4,090 deaths in the US during 2020. The 5-year survival for all patients with gallbladder cancer is 18%, however this plummets to 2% for patients with metastatic disease. Patients with gallbladder cancer frequently de...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase I/II Study of Peposertib (M3814) and Avelumab in Combination With Hypofractionated Radiation in Patients With Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies
A Phase I/II Study of Peposertib (M3814) and Avelumab in Combination With Hypofractionated Radiation in Patients With Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies
Who is this study for: Adult patients with Metastatic or Locally Advanced Unresectable Solid Tumor or Cholangiocarcinoma or Gallbladder Carcinoma
Enrollment Status: Recruiting
Publish Date: February 20, 2025
Intervention Type: Drug, Procedure, Radiation
Study Drugs: Avelumab, Peposertib
Study Phase: Phase 1/Phase 2

Summary: This phase I/II trial studies the best dose and side effects of peposertib and to see how well it works with avelumab and hypofractionated radiation therapy in treating patients with solid tumors and hepatobiliary malignancies that have spread to other places in the body (advanced/metastatic). Peposertib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Imm...

View All Clinical Trials